Day: December 25, 2022

Advantech, a medical computing platform service and solution provider, showcased its latest medical computer solutions for hospitals and the medical OEM industry at the MEDICA 2022 trade show. Visitors received live demonstrations within the specific applications inside hospitals and clinics, involving solutions for the digital operating room, patient rooms, nurse wards, critical care, and mobile care systems, amongst other medical environments. Advantech medical certified computing solutions are ready to implement for hospitals but also with strong customisation capabilities for the…

Digital health company Ada Health has announced that Ada Assess has successfully been certified as a Class IIa medical device under the European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR). The EU-MDR is the medical device regulation applied by the European Commission. It was established to set EU-wide rules to improve the safety and quality of medical devices and provide transparency for patients to ensure public health and patient safety. The Ada Assess enterprise solution is among the first…

Roche has launched its next-generation portfolio SARS-CoV-2 rapid antigen tests (“2.0”) for self-testing and professional use in countries accepting the CE mark. In doing so, Roche builds upon its portfolio of COVID-19 rapid testing solutions with three new test configurations that feature an improved capture antibody and the addition of new digital data sharing capabilities to all tests. Using nasopharyngeal and nasal swab samples, respectively, the tests deliver results in as few as 15 minutes, aiding in the diagnosis of…

Biocomposites, a medical device company that engineers, manufactures, and markets world leading products for use in infection management in bone and soft tissue has announced that STIMULAN has received a new broad-based approval as an antibiotic carrier for use in bone and soft tissue in Mexico. The approval, granted by COFEPRIS, the Mexican Regulatory Authority, authorises the use of STIMULAN as a carrier of substances such as antibiotics that are chosen by the surgeon as part of their infection treatment…

A new breast cancer diagnostic technology which could prevent deaths and save money for organisations like the NHS has been unveiled. The tool, invented in the UK by medical firm Digistain, has passed clinical studies and peer review, gaining market clearance from the Medicines & Healthcare Regulatory Agency. The tool will help to slash waiting times, reduce the use of chemotherapy and cut the current the COVID-19 hospital backlog. This radical artificial intelligence concept was developed at London’s Imperial College…